Myfortic Tablet, Delayed Release
Product Images NDC 0078-0386
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Myfortic (NDC 0078-0386). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel Novartis Ndc 0078-0385-66 Myfortic® (mycophenolic Acid*) Delayed-release Tablets *as Mycophenolate Sodium Dispense The Accompanying Medication Guide To Each Patient. 120 Tablets 180 mg Rx Only (Myfortic 02)
Principal Display Panel Novartis Ndc 0078-0386-66 Myfortic® (mycophenolic Acid*) Delayed-release Tablets *as Mycophenolate Sodium Dispense The Accompanying Medication Guide To Each Patient. 120 Tablets 360 mg Rx Only (Myfortic 03)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.